RVV Profile
- Sector: Health Technology
- Industry: Pharmaceuticals: Major
Revive Therapeutics Ltd. engages in the research, development, and commercialization of novel therapies and technologies for the medical cannabis and cannabinoid pharmaceuticals markets. It offers the Relicann, a proprietary hemp-based cannabidiol chewing gum for the health and wellness. Its novel cannabinoid delivery technology targets diseases and disorders such as pain, inflammation, and wound care. The company was founded by Fabio Chianelli on March 27, 2012 and is headquartered in Vaughan, Canada.
https://s3.tradingview.com/external-embedding/embed-widget-mini-symbol-overview.js https://s3.tradingview.com/external-embedding/embed-widget-financials.js[bbp-topic-index]
[bbp-topic-form]
Recent News
- Naturally Splendid Prepares to Receive Third Container of NATERA Plant Based Foods
- Cresco Labs Announces Proposed Offering of Subordinate Voting Shares
- Columbia Care Receives Provisional License for Adult Use at its Patriot Care Dispensary in Downtown Boston
- MediPharm Labs Appoints Warren Everitt, CEO Australia Pacific, to Board of DirectorsWa
- Village Farms International Announces US$135 Million Registered Direct Offering
- Namaste Technologies Announces Bought Deal Public Offering
- Aurora Announces Agreement with Great North Distributors Inc. For Canadian Retail Sales Execution
- Cresco Labs to Expand Into Florida Through Acquisition of Bluma Wellness Inc.
- Body and Mind Provides Corporate Update
- PeakBirch Logic Expands CBD Sales into B2B with Collaborative Agreement with Namaste Technologies
